Improving Alignment in Drug Development and the Clinical Trial Ecosystem
- Presenter: Georgie Rack & Owen Bryant
Contributor
Rob Freishtat
Rob Freishtat
In this episode, we dive into the challenges and opportunities of improving alignment across stakeholders in drug development, from early research to regulatory approval.
Our special guest, Rob Freishtat from Uncommon Cures shares insights on fostering better collaboration between the main stakeholders. Together, we explore who these stakeholders are, the real-world strategies to streamline communication, enhance transparency, and accelerate innovation in bringing safe, effective therapies to patients with rare diseases.
